# Effect of Vitamin D on Hormonal, Metabolic and Cardiovascular Risk Factors in Patients With Polycystic Ovary Syndrome

> **NCT02513381** · NA · COMPLETED · sponsor: **Hull University Teaching Hospitals NHS Trust** · enrollment: 40 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **OTHER:** Vitamin D3, 3200IU
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02513381
- **Lead sponsor:** Hull University Teaching Hospitals NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02513381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02513381, "Effect of Vitamin D on Hormonal, Metabolic and Cardiovascular Risk Factors in Patients With Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02513381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*